期刊文献+

原发性高血压患者血浆肾上腺髓质素、内皮素-1的改变 被引量:11

Changes of Plasma Adrenomedullin and Endothelin-1 in Essential Hypertension Patients
下载PDF
导出
摘要 目的 :观察高血压患者血浆肾上腺髓质素 (ADM)和内皮素 - 1(ET- 1)的改变。  方法 :用特异性的放射免疫法测定 5 2例原发性高血压患者 [其中高血压 期 (高血压 期组 ) 2 5例 , 期 (高血压 期组 ) 16例 , 期 (高血压 期组 ) 11例 ]血浆 ADM、ET- 1水平并与正常对照组相比较。  结果 :高血压 期组血浆 ADM、ET- 1水平显著高于高血压 期组、高血压 期组 (P<0 .0 1) ,高血压 期组、高血压 期组两者水平高于正常对照组 (P<0 .0 1) ,而高血压 期组与高血压 期组之间没有显著差异。  结论 :高血压时血管细胞为抵消或减轻 ET- 1等缩血管物质的过度分泌而代偿性的合成和分泌 ADM增多。 Objective:To assess the changes of plasma adrenomedullin(ADM)and endothelin 1(ET 1)in essential hypertensive patients. Methods:Specific radioimmunoassay was used to measure the plasma concentrations of ADM and ET 1 of 52 patients with essential hypertension among whom 25 patients were at stageⅠ,16 stageⅡand 11 stageⅢ. Results:The plasma concentrations of ADM and ET 1 of hypertension(including all 3 stage)are significantly higher than that of control.The plasma concentrations of ADM and ET 1 in severe hypertensive patients(stage Ⅲ)are significantly higher than that of in mild and moderate(stageⅠand stageⅡ)patients,but there is no statistically significant difference between the patients of stage Ⅱand stageⅠ. Conclusion:During the course of hypertension,vascular cell synthesize and secrete more ADM to compensate for the excessive secretion of ET 1.
出处 《中国循环杂志》 CSCD 北大核心 1999年第6期352-354,共3页 Chinese Circulation Journal
关键词 肾上腺髓质素 内皮素 高血压 Adrenomedullin Endothelin 1 Hypertension
  • 相关文献

参考文献1

二级参考文献2

共引文献14

同被引文献85

  • 1阮云军,向定成,邱建,张金霞,张萍,龚志华.冠状动脉痉挛患者血清一氧化氮含量的变化[J].心肺血管病杂志,2005,24(1):11-12. 被引量:22
  • 2[1]Linchtlen PR,Hugenholtz PG,Rafflenbeul W,et al.Retardition of caronary artery disease in humans by the calcium-channal blocker nifedipine:results of the INTACT study (international nifedipine trial on antitherosclerotic therapy).Cardiovascular Drugs and Therapy,1990,4∶1047-1068.
  • 3[3]Sugo S,Minamino N,Kangawa K,et al.Endothelial cells actively synthesize and secrete adrenomedullin.Biochem Biophys Res Commun,1994,201∶1160-1166.
  • 4[4]Kureishi Y,Kobayashi S,Nishimuna J,et al.Adrenomedullin decreases both cytosolic Ca2+ concentration and Ca2+-sensitivity in pig coronary arterial smooth muscle.Biochem Biophys Res Comun,1995,212∶572-579,215∶619-625.
  • 5[5]Houchi H,Yoshizumi M,Shono M,et al.Adrenomedullin stimulates calcium effluxfrom adrenal chromaffin cells in culture:Possible involvement of an Na+/Ca2+ exchange mechanism.Life Sci,1996,58∶35-40.
  • 6[6]Ishiyama Y,Kitamura K,Ichiki Y,et al.Hemodynamid effects of a novel hypertension peptide,human adrenomedullin in rats.Eur J Pharmacol,1993,241∶271-273.
  • 7Todd J, System nature of endothelial dysfunction in atherosclerosis[J]. Am J Cardiol,1995,75:71.
  • 8Celermajer DS,Sorensen KE,Gooch V,et al.Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis[J].Lancet,1992,340:1111-1115.
  • 9Higashi Y, Oshima T,Sasaki S, et al.Angiotensin-converting enzyme inhibition, but not calcium antagonism,improves a response of the renal vasculature to L-arginine in patients with essential hypertension[J]. Hypertension,1998,32:16-24.
  • 10Meeder JG,Peds HO, Blanksma PK, et al. Comparison between posirtron emission tomography myocardial perfusion imaging and intracoronary Doppler flow velocity measurements at rest and during cold pressor testing in angiographically normal coronary arteries in patients with one-vessel coronary artery disease[J]. Am J Cardiol, 1996,78:526-531.

引证文献11

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部